SG10201811494SA - Methods of treating a pulmonary bacterial infection using fluoroquinolones - Google Patents

Methods of treating a pulmonary bacterial infection using fluoroquinolones

Info

Publication number
SG10201811494SA
SG10201811494SA SG10201811494SA SG10201811494SA SG10201811494SA SG 10201811494S A SG10201811494S A SG 10201811494SA SG 10201811494S A SG10201811494S A SG 10201811494SA SG 10201811494S A SG10201811494S A SG 10201811494SA SG 10201811494S A SG10201811494S A SG 10201811494SA
Authority
SG
Singapore
Prior art keywords
methods
treating
bacterial infection
pulmonary bacterial
fluoroquinolones
Prior art date
Application number
SG10201811494SA
Other languages
English (en)
Inventor
Mike Dudley
David Griffith
Olga Rodny
Original Assignee
Horizon Orphan Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43011488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10201811494S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Horizon Orphan Llc filed Critical Horizon Orphan Llc
Publication of SG10201811494SA publication Critical patent/SG10201811494SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG10201811494SA 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoroquinolones SG10201811494SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17262509P 2009-04-24 2009-04-24

Publications (1)

Publication Number Publication Date
SG10201811494SA true SG10201811494SA (en) 2019-01-30

Family

ID=43011488

Family Applications (3)

Application Number Title Priority Date Filing Date
SG10201811494SA SG10201811494SA (en) 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoroquinolones
SG10201403512TA SG10201403512TA (en) 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoro-quinolones
SG2011076932A SG175288A1 (en) 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoro-quinolones

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10201403512TA SG10201403512TA (en) 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoro-quinolones
SG2011076932A SG175288A1 (en) 2009-04-24 2010-04-22 Methods of treating a pulmonary bacterial infection using fluoro-quinolones

Country Status (27)

Country Link
US (2) US20120035166A1 (es)
EP (1) EP2421539B1 (es)
JP (2) JP6179844B2 (es)
KR (1) KR20120034626A (es)
CN (2) CN107050032A (es)
AU (1) AU2010238765B2 (es)
BR (1) BRPI1006626B8 (es)
CA (1) CA2759874C (es)
CL (1) CL2011002649A1 (es)
CO (1) CO6450642A2 (es)
CY (1) CY1122525T1 (es)
DK (1) DK2421539T3 (es)
ES (1) ES2755754T3 (es)
HR (1) HRP20191951T1 (es)
HU (1) HUE046595T2 (es)
IL (1) IL215777A (es)
LT (1) LT2421539T (es)
MX (1) MX339077B (es)
MY (1) MY178871A (es)
NZ (1) NZ596245A (es)
PL (1) PL2421539T3 (es)
PT (1) PT2421539T (es)
RU (1) RU2535056C2 (es)
SG (3) SG10201811494SA (es)
SI (1) SI2421539T1 (es)
WO (1) WO2010124141A1 (es)
ZA (1) ZA201107903B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546423B2 (en) * 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
WO2010042549A1 (en) 2008-10-07 2010-04-15 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
NZ592717A (en) 2008-10-07 2013-03-28 Mpex Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation
ES2739979T3 (es) 2009-09-04 2020-02-05 Horizon Orphan Llc Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
JP6426696B2 (ja) * 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
JP6966835B2 (ja) * 2016-02-05 2021-11-17 ホライズン オーファン リミテッド ライアビリティ カンパニー 嚢胞性線維症のためのフルオロキノロン製剤
CN108849939B (zh) * 2018-07-31 2021-02-19 广东省农业科学院植物保护研究所 盐酸左氧氟沙星在制备用于防治烟草青枯病的农药制剂中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003075889A1 (en) * 2002-03-05 2003-09-18 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
RU2255757C1 (ru) * 2004-06-22 2005-07-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Пептидное соединение, восстанавливающее функцию органов дыхания
CA2900093C (en) * 2005-05-18 2018-11-13 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
MX2010012452A (es) * 2008-05-15 2011-03-15 Novartis Ag Star Suministro pulmonar de una fluoro-quinolona.
NZ592717A (en) 2008-10-07 2013-03-28 Mpex Pharmaceuticals Inc Aerosol fluoroquinolone formulations for improved pharmacokinetics comprising levofloxacin or ofloxacin and a di- or trivalent cation

Also Published As

Publication number Publication date
EP2421539A4 (en) 2014-01-29
MY178871A (en) 2020-10-21
IL215777A0 (en) 2012-01-31
ZA201107903B (en) 2013-01-30
JP6179844B2 (ja) 2017-08-16
EP2421539B1 (en) 2019-10-23
SI2421539T1 (sl) 2019-12-31
HUE046595T2 (hu) 2020-03-30
LT2421539T (lt) 2019-12-10
US20120035166A1 (en) 2012-02-09
CA2759874A1 (en) 2010-10-28
MX339077B (es) 2016-05-10
KR20120034626A (ko) 2012-04-12
NZ596245A (en) 2013-11-29
HRP20191951T1 (hr) 2021-05-14
BRPI1006626A2 (pt) 2020-07-28
WO2010124141A1 (en) 2010-10-28
JP2016053041A (ja) 2016-04-14
PT2421539T (pt) 2019-11-22
DK2421539T3 (da) 2019-11-18
JP2012524811A (ja) 2012-10-18
CN102427815A (zh) 2012-04-25
EP2421539A1 (en) 2012-02-29
PL2421539T3 (pl) 2020-02-28
AU2010238765B2 (en) 2014-12-18
IL215777A (en) 2017-09-28
SG175288A1 (en) 2011-11-28
CY1122525T1 (el) 2021-01-27
CO6450642A2 (es) 2012-05-31
RU2535056C2 (ru) 2014-12-10
CL2011002649A1 (es) 2012-06-22
SG10201403512TA (en) 2014-08-28
CA2759874C (en) 2016-11-08
RU2011145430A (ru) 2013-05-27
AU2010238765A1 (en) 2011-11-10
ES2755754T3 (es) 2020-04-23
US20210015811A1 (en) 2021-01-21
BRPI1006626B8 (pt) 2021-05-25
CN107050032A (zh) 2017-08-18
MX2011011190A (es) 2012-02-13
BRPI1006626B1 (pt) 2021-05-11
JP6228580B2 (ja) 2017-11-08

Similar Documents

Publication Publication Date Title
SG10201811494SA (en) Methods of treating a pulmonary bacterial infection using fluoroquinolones
PH12014502683B1 (en) NOVEL á-LACTAMASE INHIBITOR AND METHOD FOR PREPARING THE SAME
NZ593111A (en) Antibacterial compounds
NZ602544A (en) Crystalline forms of a macrolide, and uses therefor
MX348974B (es) Derivados 1,6 - diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
MX340490B (es) Derivados de pirazolo [1, 5a] pirimidina y de tieno [3, 2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
SG178952A1 (en) Chemical compounds
MX366793B (es) Metodos para preparar oxazolidinonas y composiciones que las contienen.
WO2012135016A3 (en) Inhibition of bacterial biofilms and microbial growth with imidazole derivatives
WO2018208987A3 (en) Antibacterial compounds
MX2021003084A (es) Compuestos antibacterianos.
GEP20166481B (en) (crystalline forms of hydrochloride salt of (4a-r, 9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2, 3, 4, 4a, 9, 9a-hexa- hydro-1h-indeno [2, 1-b] pyridine-6-carbonitrile and their use as hsd 1 inhibitors
MX2013002851A (es) Inhibidores de tonum pectinacetilesterasa y metodos de su uso.
WO2014022382A3 (en) Antibacterial protein kinase inhibitors
NZ628927A (en) Compounds and methods for treating candidiasis and aspergillus infections
MX355561B (es) Proceso para hacer inhibidores de girasa y topoisomerasa iv.
IN2012DN03846A (es)
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
MX2013007053A (es) Uso de compuestos que libera peroxigeno libre de nitrogeno para reducir el crecimiento de microorganismos contaminates en la fermentacion de etanol.
MX2015012472A (es) Derivados de manosa para el tratamiento de infecciones bacterianas.
NZ713357A (en) Antimicrobial compounds and methods of making and using the same
EA201100754A1 (ru) [4-(1-аминоэтил)циклогексил]метиламины в качестве антибактериальных средств